Steven R Whittaker

ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Venues

Molecular cancer research : MCR

Oncogene

British journal of cancer

Cellular oncology (Dordrecht)

Engitix Therapeutics

Institute of Cancer Research (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Engitix Therapeutics

United Kingdom

Senior Scientist and Head of Oncology

The Institute of Cancer Research

United Kingdom

Team Leader, Molecular Drug Resistance :: Division of Cancer Therapeutics

Broad Institute

United States

Postdoctoral Fellow

Institute of Cancer Research

United Kingdom

Postdoctoral Fellow

Education History

Institute of Cancer Research

United Kingdom

PHD

Brunel University

United Kingdom

BSC

Publications

Walid Al-Akkad, Pilar Acedo, Maria-Giovanna Vilia, Luca Frenguelli, Alexander Ney, Irene Rodriguez-Hernandez, Peter Lawrence Zaki Labib, Domenico Tamburrino, Gabriele Spoletini, Andrew R Hall, Simone Canestrari, Anna Osnato, Jose Garcia-Bernardo, Leinal Sejour, Vessela Vassileva, Ioannis S Vlachos, Giuseppe Fusai, Tu Vinh Luong, Steven R Whittaker, Stephen P Pereira, Ludovic Vallier, Massimo Pinzani, Krista Rombouts, Giuseppe Mazza
Tissue-Specific Human Extracellular Matrix Scaffolds Promote Pancreatic Tumour Progression and Chemotherapy Resistance. Cells 11 (22) (2022)
Alexandros Georgiou, Adam Stewart, Georgios Vlachogiannis, Lisa Pickard, Nicola Valeri, David Cunningham, Steven R Whittaker, Udai Banerji
A phospho-proteomic study of cetuximab resistance in KRAS/NRAS/BRAFV600 wild-type colorectal cancer. Cellular oncology (Dordrecht) 44 (5) (2021)
Charlotte K Milton, Annette J Self, Paul Andrew Clarke, Udai Banerji, Federica Piccioni, David E Root, Steven R Whittaker
A Genome-scale CRISPR Screen Identifies the ERBB and mTOR Signaling Networks as Key Determinants of Response to PI3K Inhibition in Pancreatic Cancer. Molecular cancer therapeutics 19 (7) (2020)
Alexandros Georgiou, Adam Stewart, David Cunningham, Udai Banerji, Steven R Whittaker
Inactivation of NF1 Promotes Resistance to EGFR Inhibition in KRAS/NRAS/BRAFV600 -Wild-Type Colorectal Cancer. Molecular cancer research : MCR 18 (6) (2020)
Teresa Delgado-Goñi, Teresa Casals Galobart, Slawomir Wantuch, Deimante Normantaite, Martin O Leach, Steven R Whittaker, Mounia Beloueche-Babari
Increased inflammatory lipid metabolism and anaplerotic mitochondrial activation follow acquired resistance to vemurafenib in BRAF-mutant melanoma cells. British journal of cancer 122 (1) (2019)
Steve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, Melanie Valenti, Gary Box, Liam Jenkins, Caterina Mancusi, Annette Self, Floriana Manodoro, Ioannis Assiotis, Penny Robinson, Ritika Chauhan, Alistair G Rust, Nik Matthews, Katherine Eason, Khurum Khan, Naureen Starling, David Cunningham, Anguraj Sadanandam, Clare M Isacke, Vladimir Kirkin, Nicola Valeri, Steven R Whittaker
Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer. Oncogene 38 (10) (2018)

Steven R Whittaker.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Steven R Whittaker